TrialBMC infectious diseases2014

A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan.

Hans-Christian Stahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.